Skip to main content

Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft Platforms

(recording date 03/18/2021) Grace Berryhill, Ph.D. speaks about patient-derived xenograft (PDX) mice, modeling the heterogeneity of human cancer, and conducting more translationally relevant cancer research studies. Watch this video to learn about: * A collection of more than 400 PDX models established in partnership with a consortium of cancer hospitals and clinical trial teams * How the genetics, pathology, and treatment response of PDX tumors reflect clinical observations * Using tumor-bearing humanized NSG mice as an innovative platform to evaluate therapies * Finding relevant cancer models and characterization data using the “Mouse Models of Human Cancer Database” Recorded Q&A session begins at 52:05:15.